Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Szebeni J, Storm G, Ljubimova JY, Castells M, Phillips EJ, Turjeman K, Barenholz Y, Crommelin DJA and Dobrovolskaia MA

Journal title: Nature Nanotechnology

Journal number: 17(4)

Journal publisher: Nature Publishing Group

Published year: 2022

Published pages: 337-346

DOI identifier: 10.1038/s41565-022-01071-x

ISSN: 1748-3387